Related Experiment Video
Updated: Mar 10, 2026

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
Mind the gap in clinical trials: A participatory action analysis with citizen collaborators
Amy Price1, Su May Liew2, Jo Kirkpatrick3
1Department of Primary Health Care Sciences, University of Oxford, UK.
Abstract:
What are the strengths, gaps, expectations, and barriers to research engagement in clinical trials as communicated through social media? Clinical trials test treatments to provide reliable information for safety and effectiveness. Trials are building blocks in which what is learned in earlier research can be used to improve treatments, compare alternatives, and improve quality of life. For 20 years, the percentages of clinical trials volunteers have decreased whereas the costs of running clinical trials have multiplied. Participants enroll in trials to access latest treatments, to help others, and to advance science, but there is growing unrest. The priorities of those running the trials differ from those of the participants, and the roles for public research involvement lack clarity. Changes to bridge these gaps in the research culture are proposed through the use of participatory action research (PAR) in which stakeholders collaborate to improve research methodology, galvanize citizen participation, multiply health knowledge, problem-solve barriers to access, and explore the value of research volunteers as collaborators. PAR enabled the inclusion of citizens as full collaborators. Social media data were gathered for 120 days until saturation was reached. De-identified data were organized into a Strengths Weaknesses, Opportunities and Threats framework and coded into themes for analysis. After the analysis, the authors prioritized potential solutions for improving research engagement. Strengths and opportunities remained constant through trial phases, disease burdens, and interventions. Threats included alienation, litigation, disparity, and shaming. Poor management and barriers to inclusion were identified as weaknesses. Opportunities included improving resource management and information quality. Barriers were minimized when relationships between staff and participants were inclusive, respectful, tolerant, and open to change. Participants' communications ranged from fulfillment through trial involvement to disparities and rights violations. PAR provides a safe space without power imbalances in which researchers and citizen worked as equals rather than as researchers and objects of research.
Insights
Participatory Action Research (PAR) enhances clinical trial engagement by fostering collaboration between researchers and citizens. This approach addresses barriers and improves research culture, leading to better participant experiences and outcomes.
Area of Science:
- Clinical Research
- Public Health
- Social Science Research
Background:
- Clinical trials are crucial for evaluating treatment safety and effectiveness, yet volunteer participation has declined while costs have risen.
- A disconnect exists between trial organizers' priorities and participants' expectations, with unclear roles for public involvement.
- Existing research culture presents barriers to engagement, necessitating innovative approaches to bridge gaps between researchers and participants.
Purpose of the Study:
- To explore strengths, gaps, expectations, and barriers to research engagement in clinical trials using social media communication.
- To propose and evaluate the use of Participatory Action Research (PAR) as a method to improve clinical trial engagement and collaboration.
- To identify actionable solutions for enhancing the research culture and participant involvement in clinical trials.
Main Methods:
- Gathered de-identified social media data over 120 days until data saturation.
- Analyzed data using a Strengths, Weaknesses, Opportunities, and Threats (SWOT) framework and thematic coding.
- Employed Participatory Action Research (PAR) principles, enabling citizens as full collaborators in the research process.
Main Results:
- Strengths and opportunities for engagement remained consistent across trial phases, disease types, and interventions.
- Identified threats including alienation, litigation, disparity, and shaming, alongside weaknesses such as poor management and inclusion barriers.
- Highlighted opportunities in resource management and information quality, with barriers reduced through inclusive, respectful staff-participant relationships.
Conclusions:
- Participatory Action Research (PAR) creates an equitable environment for researchers and citizens to collaborate as equals.
- Addressing barriers requires fostering inclusive, respectful, and open relationships between research staff and participants.
- Improving clinical trial engagement necessitates a shift towards a more collaborative research culture that values participant contributions.
More Related Videos
06:16Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
Published on: June 6, 2020
09:33Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
Published on: December 23, 2022
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Ethics in Research
Community Based Intervention
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Bioavailability Study Design: Healthy Subjects Versus Patients
Blinding